Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15370117 | 1.00 | CYP3A4 (0.31) | CYP3A4ALOX15 | |
| SCHEMBL11295201 | 1.00 | CYP3A4 (0.31) | CYP3A4ALOX15 | |
| SCHEMBL11319387 | 0.98 | — | — | |
| SCHEMBL11319380 | 0.82 | — | — | |
| SCHEMBL11319384 | 0.82 | — | — | |
| SCHEMBL2733397 | 0.74 | CYP3A4 (0.43) | CYP3A4ALOX15 | |
| SCHEMBL14738495 | 0.74 | CYP3A4 (0.43) | CYP3A4ALOX15 | |
| SCHEMBL2732951 | 0.72 | CYP3A4 (0.42) | CYP3A4ALOX15 | |
| SCHEMBL4558556 | 0.72 | ALOX15 (0.40) | CYP3A4ALOX15 | |
| SCHEMBL4558558 | 0.72 | ALOX15 (0.40) | CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2665701-A2 | DIAZENIUMDIOLATE DERIVATIVES | Merck Sharp & Dohme Corp. (US) | 2013-11-27 | — | — | EP | claimed |
| WO-2012099770-A2 | DIAZENIUMDIOLATE DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2012-07-26 | — | — | WO | claimed |
| EP-2704568-B1 | DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES | MERCK SHARP & DOHME (US) | 2018-01-24 | — | — | EP | disclosed |
| EP-2683687-B1 | HETEROCYCLIC DERIVATIVES CONTAINING PRIMARY AMINO GROUPS AND DIAZENIUMDIOLATES | MERCK SHARP & DOHME (US) | 2017-04-19 | — | — | EP | disclosed |
| US-9272987-B2 | Diazeniumdiolate cyclohexyl derivatives | MERCK SHARP & DOHME CORP. (US) | 2016-03-01 | — | — | US | disclosed |
| US-20140088048-A1 | DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2014-03-27 | — | — | US | disclosed |
| EP-2704568-A1 | DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES | Merck Sharp & Dohme Corp. (US) | 2014-03-12 | — | — | EP | disclosed |
| EP-2683687-A1 | PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES | Merck Sharp & Dohme Corp. (US) | 2014-01-15 | — | — | EP | disclosed |
| US-8361994-B2 | Primary amine diazeniumdiolate heterocyclic derivatives | MERCK SHARP & DOHME CORP (US) | 2013-01-29 | — | — | US | disclosed |
| WO-2012151114-A1 | DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2012-11-08 | — | — | WO | disclosed |
| WO-2012122077-A1 | PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2012-09-13 | — | — | WO | disclosed |
| US-20120232039-A1 | PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES | MERCK SHARP & DOHME LLC | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120232039-A1 | PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES | EDNRA, PAH, EDNRB | CYP3A4 1761/4885ALOX15 1199/4885 |
| US-20140088048-A1 | DIAZENIUMDIOLATE CYCLOHEXYL DERIVATIVES | CBR3, OR10J3, CBR1 | CYP3A4 136/4885ALOX15 3638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.